Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy

Immunology Letters

Volumn 151, Issue 1-2, 2013, Pages 23-30

  Pulsawat, Pinya ^a   Pitakpolrat, Patrawadee ^a   Prompetchara, Eakachai ^a   Kaewamatawong, Theerayuth ^a   Techakriengkrai, Navapon ^a   Sirivichayakul, Sunee ^a   Buranapraditkun, Supranee ^a   Hannaman, Drew ^b   Ruxrungtham, Kiat ^a   Jacquet, Alain ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Ichor Medical Systems Inc   (United States)

Author keywords

Der p 2; DNA vaccine; Electroporation; HDM allergy; Mice model

Indexed keywords

DER P 2 ALLERGEN; DNA VACCINE; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; DNA SEQUENCE; ELECTROPORATION; HOUSE DUST ALLERGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; INTRON; LOW DRUG DOSE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; CELL LINE; GENE EXPRESSION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE; VACCINES, DNA;

EID: 84876342274     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.01.013     Document Type: Article

References (43)

1. Zock J.P., Heinrich J., Jarvis D., Verlato G., Norbäck D., Plana E., et al. Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J Allergy Clin Immunol 2006, 118:682-690.
2. Valenta R., Campana R., Marth K., van Hage M. Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med 2012, 272:144-157.
3. Linhart B., Valenta R. Vaccines for allergy. Curr Opin Immunol 2012, 24:354-360.
4. Valenta R., Linhart B., Swoboda I., Niederberger V. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy 2011, 66:775-783.
5. Jacquet A. The role of innate immunity activation in house dust mite allergy. Trends Mol Med 2011, 17:604-611.
6. Thomas W.R., Hales B.J., Smith W.A. House dust mite allergens in asthma and allergy. Trends Mol Med 2010, 16:321-328.
7. Weghofer M., Thomas W.R., Kronqvist M., Mari A., Purohit A., Pauli G., et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008, 38:959-965.
8. Trompette A., Divanovic S., Visintin A., Blanchard C., Hegde R.S., Madan R., et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009, 457:585-588.
9. Osterlund C., Grönlund H., Polovic N., Sundström S., Gafvelin G., Bucht A. The non-proteolytic house dust mite allergen Der p 2 induce NF-kappaB and MAPK dependent activation of bronchial epithelial cells. Clin Exp Allergy 2009, 39:1199-1208.
10. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 2008, 9:776-788.
11. Hsu C.H., Chua K.Y., Tao M.H., Lai Y.L., Wu H.D., Huang S.K., et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyper responsiveness in vivo by genetic immunization. Nat Med 1996, 2:540-544.
12. Hsu C.H., Chua K.Y., Tao M.H., Huang S.K., Hsieh K.H. Inhibition of an in vivo allergen-specific IgE response in mice by direct gene transfer. Int Immunol 1996, 8:1405-1411.
13. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996, 93:5141-5145.
14. Huang S.K., Chua K.Y., Hsieh K.H. Allergen gene transfer. Curr Opin Immunol 1997, 9:800-804.
15. Liu M.A. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011, 239:62-84.
16. Rosati M., von Gegerfelt A., Roth P., Alicea C., Valentin A., Robert-Guroff M., et al. DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol 2005, 79:8480-8492.
17. Dale C.J., De Rose R., Wilson K.M., Croom H.A., Thomson S., Coupar B.E., et al. Australian Thai HIV Vaccine Consortium Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12. Vaccine 2004, 23:188-197.
18. Coban C., Ishii K.J., Gursel M., Klinman D.M., Kumar N. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol 2005, 78:647-655.
19. Sardesai N.Y., Weiner D.B. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 2011, 23:421-429.
20. Dale C.J., Thomson S., De Rose R., Ranasinghe C., Medveczky C.J., Pamungkas J., et al. Prime-boost strategies in DNA vaccines. Methods Mol Med 2006, 127:171-197.
21. Kim N., Kwon S.S., Lee J., Kim S., Yoo T.J. Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy. Clin Mol Allergy 2006, 4:4.
22. Gabler M., Scheiblhofer S., Kern K., Leitner W.W., Stoecklinger A., Hauser-Kronberger C., et al. Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization. J Allergy Clin Immunol 2006, 118:734-741.
23. Bauer R., Scheiblhofer S., Kern K., Gruber C., Stepanoska T., Thalhamer T., et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 2006, 118:269-276.
24. Campana R., Vrtala S., Maderegger B., Jertschin P., Stegfellner G., Swoboda I., et al. Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly. J Allergy Clin Immunol 2010, 126:1024-1031.
25. Thalhamer T., Dobias H., Stepanoska T., Pröll M., Stutz H., Dissertori O., et al. Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol 2010, 125:926-934.
26. James L.K., Shamji M.H., Walker S.M., Wilson D.R., Wachholz P.A., Francis J.N., et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011, 127:509-516.
27. Tan L.K., Huang C.H., Kuo I.C., Liew L.M., Chua K.Y. Intramuscular immunization with DNA construct containing Der p 2 and signal peptide sequences primed strong IgE production. Vaccine 2006, 24:5762-5771.
28. Zhou B., Yuan J., Zhou Y., Yang J., James A.W., Nair U., et al. The attenuation of cockroach allergy by DNA vaccine encoding cockroach allergen Bla g 2. Cell Immunol 2012, 278:120-124.
29. Zhou B., Ensell M., Zhou Y., Nair U., Glickstein J., Kermany M.H., et al. Prevention and treatment of DNA vaccine encoding cockroach allergen Bla g 1 in a mouse model of allergic airway inflammation. Allergy 2012, 67:166-174.
30. Zhang F., Huang G., Hu B., Song Y., Shi Y. Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination. Clin Vaccine Immunol 2011, 18:807-814.
31. Schmid D., Pypaert M., Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26:79-92.
32. Meerak J., Wanichwecharungruang S.P., Palaga T. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Vaccine 2012, [pii: S0264-410X(12)01725-2].
33. Li G.P., Liu Z.G., Liao B., Zhong N.S. Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cell Mol Immunol 2009, 6:45-50.
34. Wu C.J., Li T.L., Huang H.W., Tao M.H., Chan Y.L. Development of an effective Japanese encephalitis virus-specific DNA vaccine. Microbes Infect 2006, 8:2578-2586.
35. Zhang X., Divangahi M., Ngai P., Santosuosso M., Millar J., Zganiacz A., et al. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine 2007, 25:1342-1352.
36. Dobaño C., Widera G., Rabussay D., Doolan D.L. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine 2007, 25:6635-6645.
37. Best S.R., Peng S., Juang C.M., Hung C.F., Hannaman D., Saunders J.R., et al. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009, 27:5450-5459.
38. van Drunen Littel-van den Hurk S., Luxembourg A., Ellefsen B., Wilson D., Ubach A., Hannaman D., et al. Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle. Vaccine 2008, 26:5503-5509.
39. Roberts T.L., Sweet M.J., Hume D.A., Stacey K.J. Species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J Immunol 2005, 174:605-608.
40. Kojima Y., Xin K.Q., Ooki T., Hamajima K., Oikawa T., Shinoda K., et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 2002, 20:2857-2865.
41. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011, 12:959-965.
42. Hallengard D., Bråve A., Isaguliants M., Blomberg P., Enger J., Stout R., et al. combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccine Ther 2012, 10:5.
43. Ranasinghe C., Ramshaw I.A. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity. Expert Rev Vaccine 2009, 8:1171-1181.